High ZNF217 mRNA levels in primary breast tumors are also of bad prognosis and associated with shorter relapse free survival (RFS) and metastasis development (5, 6), with the most discriminatory prognostic power observed in Luminal breast cancers (7). Here, ZNF217 is linked to breast cancer.